This page is not indexed by search engines while we improve data quality.

Wallentin Lars patents

Wallentin Lars is listed as an inventor on 2 patents in our database. Major assignees and classification codes are summarized below.

Inventor statistics
Metric	Value
Inventor	Wallentin Lars
Total patents	2
First publication	Mar 12, 2020
Latest publication	Dec 14, 2021

Notable patents

Publications ranked by popularity score, then publication date.

Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
US-11199552-B2 · Dec 14, 2021 · US
Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of gdf-15, natriuretic peptide, cardiac troponin or combinations thereof
US-2020081020-A1 · Mar 12, 2020 · US

Recent patents

Latest publications not already listed above.

No data yet.

Major assignees

Companies most often associated with this inventor's publications.

Top assignees for this inventor
Assignee	Patents
Medizinische Hochschule Hannover	2
Medizinischen Hochschule Hannover	1

Top CPC classifications

Most common classification codes across this inventor's patents.

Top CPC codes for this inventor
CPC	Patents
A61P43/00	2
G01N2800/325	2
G01N2333/475	2
G01N33/74	2
G01N2333/495	2